46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

16 trials found

diseases per page:

Showing 1 to 10 of 16 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04428424 (ClinicalTrials.gov)	July 5, 2020	10/6/2020	Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Cit ...	The Impact of RF, and Anti-CCP on RA Patients in Response to Etanercept	Arthritis, Rheumatoid	Drug: Enbrel	Pfizer	NULL	Completed	18 Years	N/A	All	1		Iraq
2	NCT03225950 (ClinicalTrials.gov)	February 1, 2017	19/7/2017	Interaction Between Immune Cells and Bacteria Associated With Periodontitis	Interaction Between Immune Cells and Bacteria Associated With Periodontitis	Periodontal Diseases;Periodontitis;Aggressive Periodontitis;Immunologic Disease;Microbial Disease;Pe ...	Other: In vitro stimulation of blood with periodontitis-associated- and control bacteria;Diagnostic ...	University of Copenhagen	Copenhagen University Hospital, Denmark	Completed	19 Years	60 Years	All	90		Denmark
3	NCT01975610 (ClinicalTrials.gov)	October 2013	29/10/2013	Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumat ...	A Phase 2a, 4-Week Double-Blind, Proof-of-Concept Efficacy and Safety Study of CC-292 Versus Placebo ...	Rheumatoid Arthritis	Drug: CC -292;Drug: Placebo	Celgene	NULL	Completed	18 Years	80 Years	Female	47	Phase 2	United States
4	EUCTR2011-002024-40-ES (EUCTR)	16/02/2012	14/10/2011	Proof-of-Concept Study with BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, To ...	Rheumatoid Arthritis MedDRA version: 14.0;Level: PT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: CCR1 Antagonist Product Code: BMS-817399	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting			Female: yes Male: yes	172	Phase 2	United States;Mexico;Argentina;Spain;South Africa;Russian Federation;Korea, Republic of
5	EUCTR2010-019926-15-CZ (EUCTR)	27/01/2011	01/12/2010	A Phase 2 placebo-controlled study to compare the effectiveness and safety of two doses of apremilas ...	A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY, TO COMPA ...	Rheumatoid arthritis, a chronic systemic autoimmune inflammatory disease characterized by persisten ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	210	Phase 2	United States;Czech Republic
6	NCT01285310 (ClinicalTrials.gov)	December 9, 2010	19/11/2010	Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis	A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, To Compa ...	Rheumatoid Arthritis	Drug: Apremilast 30 mg;Drug: Apremilast 20 mg;Drug: Placebo	Amgen	NULL	Terminated	18 Years	N/A	All	237	Phase 2	United States;Czechia;Poland;Spain;Czech Republic
7	EUCTR2010-019964-36-DE (EUCTR)	14/10/2010	09/06/2010	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of ...	Rheumatoid arthritis MedDRA version: 12.1;Level: LLT;Classification code 10039073;Term: Rheumatoid a ...	Product Name: CCX354 -C Product Code: CCX354 -C Other descriptive name: CCX354 Product Name: CCX354 -C Prod ...	ChemoCentryx, Inc.	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 2	Czech Republic;Hungary;Belgium;Germany
8	EUCTR2010-019964-36-CZ (EUCTR)	08/09/2010	09/06/2010	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of ...	Rheumatoid arthritis MedDRA version: 12.1;Level: LLT;Classification code 10039073;Term: Rheumatoid a ...	Product Name: CCX354 -C Product Code: CCX354 -C Other descriptive name: CCX354	ChemoCentryx, Inc.	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 2	Hungary;Czech Republic;Belgium;Germany
9	NCT01242917 (ClinicalTrials.gov)	September 2010	15/11/2010	A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partia ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of ...	Rheumatoid Arthritis	Drug: CCX-354 -C;Drug: Placebo;Drug: CCX354 -C	ChemoCentryx	NULL	Completed	18 Years	75 Years	Both	159	Phase 2	Belgium;Czech Republic;Germany;Hungary;Netherlands;Poland;Romania;Ukraine
10	EUCTR2010-019964-36-BE (EUCTR)	26/08/2010	20/05/2010	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of ...	A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of ...	Rheumatoid arthritis MedDRA version: 12.1;Level: LLT;Classification code 10039073;Term: Rheumatoid a ...	Product Name: CCX354 -C Product Code: CCX354 -C Other descriptive name: CCX354	ChemoCentryx, Inc.	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 2	Czech Republic;Hungary;Belgium;Germany

First Previous1 2Next Last